InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.12
(
-0.01%
)
Bitcoin
63,805.60
(
-0.30%
)
Post# of 6070
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

operating_line

Send PM Follow Ignore
Followers 8
Posts 921
Boards Moderated 0
Alias Born 10/07/2015

operating_line

Re: None

Tuesday, 05/09/2017 11:28:13 PM

Tuesday, May 09, 2017 11:28:13 PM

Post# of 6070
Ongoing Study: Marqibo in combination with UK ALL R3

https://clinicaltrials.gov/ct2/show/NCT02879643

Sponsor:

Therapeutic Advances in Childhood Leukemia Consortium

Collaborator:

Spectrum Pharmaceuticals, Inc

Study Start Date: July 2016
Estimated Study Completion Date: March 2019
Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up